BEYOND: a randomised controlled trial comparing efficacy and safety of individualised follitropin delta dosing in GnRH agonist versus antagonist protocols for first ovarian stimulation cycle

Authors
Category Primary study
JournalHuman Reproduction
Year 2023
This article has no abstract
Epistemonikos ID: 4c7af5c306750566f80b5221281a5cf6418f535a
First added on: Nov 03, 2023